Real-World Guide for Delivering Immunotherapy With Radiation Therapy

Area of Science:

• Oncology
• Radiation Oncology
• Immunotherapy

Background:

• Radiation therapy (RT) is a cornerstone of cancer care but faces limitations due to tumor resistance.
• Immunotherapy enhances the immune system's ability to fight cancer, complementing RT.
• Immunoradiation therapy combines RT and immunotherapy for improved tumor control and patient response.

Purpose of the Study:

• To provide a practical guide for optimizing immunoradiation therapy in clinical settings.
• To bridge the gap between research findings and clinical application of combined RT and immunotherapy.
• To synthesize current literature and clinical experience for effective treatment strategies.

Main Methods:

• Review of current literature and clinical experience on integrating immunotherapy and RT.
• Focus on pretreatment factors, immunotherapy sequencing, RT planning, and follow-up.
• Consideration of radiation dosing, fractionation, tumor size, organs at risk, and monitoring.

Main Results:

• Combined RT and immunotherapy enhance local tumor control and systemic immune activation.
• Key factors influencing outcomes include prior chemotherapy, steroid use, lymphocyte counts, and RT/immunotherapy sequencing.
• Strategies like pulsed RT and lymphocyte-sparing techniques are important for managing progression.

Conclusions:

• Tailoring immunoradiation therapy based on key influencing factors improves therapeutic outcomes.
• Integration of artificial intelligence and multidisciplinary coordination advances treatment precision.
• Personalized care in clinical oncology is enhanced through optimized immunoradiation protocols.